Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 68180-385

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 68180-385). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Drug Substance (Tramadolhcltablets Figure 01)

Chemical structure of Tramadol Hydrochloride showing its molecular components including a cyclohexane ring, methoxy group, hydroxyl group, and dimethylamine side chain with an associated hydrochloride (HCl) group.*

FDA Label Image

A. Tramadol (Tramadolhcltablets Figure 02)

A line graph depicting trough concentration (ng/mL) of Tramadol over 24 hours comparing two dosage forms: Tramadol extended-release (ER) tablets at 200 mg once daily and Tramadol immediate-release tablets at 50 mg every six hours. The x-axis represents time in hours, and the y-axis shows trough concentration values.*

FDA Label Image

B. M1 (Tramadolhcltablets Figure 03)

A line graph comparing M1 concentration (ng/mL) over 24 hours between Tramadol extended-release tablets 200 mg once daily and Tramadol tablets 50 mg every 6 hours. The x-axis shows time in hours (0 to 24), and the y-axis shows M1 concentration from 0 to 120 ng/mL. Two curves represent the concentration profiles for each dosing regimen.*

FDA Label Image

Figure 3 (Tramadolhcltablets Figure 04)

A line graph showing the percentage of patients achieving a response on the y-axis versus the response threshold (percent improvement from baseline) on the x-axis for Tramadol Hydrochloride Extended-Release tablets in 100 mg, 200 mg, 300 mg, and 400 mg strengths compared to placebo. The graph illustrates pain responder analysis from Study 023 WOMAC.*

FDA Label Image

Figure4 (Tramadolhcltablets Figure 05)

A line graph titled 'Tramadol HCl ER Tablets Study 016 Arthritis Pain Intensity VAS Responder Analysis,' showing the percent of patients achieving various response thresholds of improvement from baseline. The graph compares results between TRAMADOL ER TABLETS and placebo, with TRAMADOL ER TABLETS consistently showing higher patient response rates across response thresholds ranging from 0% to 100% improvement.*

FDA Label Image

100mg-30tabs (Tramadolhcltablets Figure 06)

Label for Tramadol Hydrochloride Extended-Release Tablets 100 mg, oral dosage form by Lupin Pharmaceuticals, Inc. The label states each tablet contains 100 mg tramadol hydrochloride and includes storage instructions, dosage administration notes, and manufacturer information. The package contains 30 tablets and indicates it is a prescription-only medication.*

FDA Label Image

200mg-30tabs (Tramadolhcltablets Figure 07)

Tramadol Hydrochloride Extended-Release Tablets 200 mg label for oral extended-release tablets in a 30-tablet package. Manufactured for Lupin Pharmaceuticals, Inc., this label includes dosage instructions to take once daily, storage conditions, and a barcode. The label features green, light blue, and dark blue design elements with black text.*

FDA Label Image

300mg-30tabs (Tramadolhcltablets Figure 08)

Label for Tramadol Hydrochloride Extended-Release Tablets 300 mg by Lupin Pharmaceuticals, Inc. The label states the dosage form as extended-release oral tablets with a package size of 30 tablets. Storage instructions specify maintaining room temperature between 15° to 30°C (59° to 86°F). The label includes a barcode and indicates the product is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.